WeVote
Log In

Bill

Bill

LB 949

Change provisions relating to the prescription drug monitoring program, the statewide health information exchange, and the Health Information Technology Board

109th Legislature (2025-2026) Introduced by Beau Ballard

LB 949 modifies Nebraska's prescription drug monitoring program, health information exchange, and Health Information Technology Board governance to improve coordination and oversight.

Referred to Health and Human Services Committee
0
WeVote Research Nonpartisan
Bill Summary · LB 949

Legislative bill overview

LB 949 modifies Nebraska's prescription drug monitoring program (PDMP), statewide health information exchange (HIE), and governance of the Health Information Technology Board. The bill adjusts how these systems operate and coordinate, though specific substantive changes are not detailed in the current action history available.

Why is this important

Prescription drug monitoring programs and health information exchanges are critical infrastructure for combating opioid misuse, preventing drug diversion, and improving care coordination across providers. Changes to these systems can significantly impact patient safety, prescriber accountability, and healthcare system efficiency across the state.

Potential points of contention

  • Privacy vs. access balance – Expanding data sharing through HIE or PDMP may raise concerns about patient privacy protection and appropriate use safeguards
  • Implementation costs – Changes to monitoring systems and board governance could impose unfunded mandates on healthcare providers and pharmacies
  • Prescriber burden – Modifications to PDMP requirements might increase or decrease documentation and compliance obligations for medical professionals

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.